Avalon Technologies Limited (BOM:543896)
India · Delayed Price · Currency is INR 884.60
-8.70 (-0.97%)
At close: Aug 12, 2025
Revance Therapeutics Revenue
Avalon Technologies had revenue of 3.23B INR in the quarter ending June 30, 2025, with 62.08% growth. This brings the company's revenue in the last twelve months to 12.22B, up 46.95% year-over-year. In the fiscal year ending March 31, 2025, Avalon Technologies had annual revenue of 10.98B with 26.63% growth.
Revenue (ttm)
12.22B
Revenue Growth
+46.95%
P/S Ratio
4.81
Revenue / Employee
14.72M
Employees
830
Market Cap
58.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10.98B | 2.31B | 26.63% |
| Mar 31, 2024 | 8.67B | -775.51M | -8.21% |
| Mar 31, 2023 | 9.45B | 1.04B | 12.37% |
| Mar 31, 2022 | 8.41B | 1.50B | 21.76% |
| Mar 31, 2021 | 6.90B | 486.04M | 7.57% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,839.41B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,503.84B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 639.28B |